May 2, 2018 / 8:31 PM / in 19 days

BRIEF-Anika Therapeutics Q1 Loss Per Share $0.46

Anika Therapeutics Inc:

* Q1 LOSS PER SHARE $0.46

* Q1 REVENUE $21.3 MILLION VERSUS I/B/E/S VIEW $24.3 MILLION

* Q1 EARNINGS PER SHARE VIEW $0.16 — THOMSON REUTERS I/B/E/S

* NOW EXPECTS TOTAL REVENUE GROWTH TO BE FLAT FOR FULL YEAR OF 2018

* TOTAL OPERATING EXPENSES ARE EXPECTED TO BE IN HIGH $90 MILLION RANGE FOR FULL YEAR OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below